vs
Side-by-side financial comparison of Adient plc (ADNT) and Quest Diagnostics (DGX). Click either name above to swap in a different company.
Adient plc is the larger business by last-quarter revenue ($3.6B vs $2.9B, roughly 1.3× Quest Diagnostics). Quest Diagnostics runs the higher net margin — 9.7% vs -0.6%, a 10.3% gap on every dollar of revenue. On growth, Quest Diagnostics posted the faster year-over-year revenue change (9.2% vs 4.3%). Over the past eight quarters, Quest Diagnostics's revenue compounded faster (9.9% CAGR vs -1.4%).
Adient plc is an American, Irish-domiciled company that operates as the largest manufacturer of automotive seating for customers worldwide and is based in Plymouth, Michigan, United States.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
ADNT vs DGX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.6B | $2.9B |
| Net Profit | $-22.0M | $281.0M |
| Gross Margin | 6.0% | — |
| Operating Margin | 1.1% | 15.4% |
| Net Margin | -0.6% | 9.7% |
| Revenue YoY | 4.3% | 9.2% |
| Net Profit YoY | — | 12.0% |
| EPS (diluted) | $-0.28 | $2.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.9B | ||
| Q4 25 | $3.6B | $2.8B | ||
| Q3 25 | $3.7B | $2.8B | ||
| Q2 25 | $3.7B | $2.8B | ||
| Q1 25 | $3.6B | $2.7B | ||
| Q4 24 | $3.5B | $2.6B | ||
| Q3 24 | $3.6B | $2.5B | ||
| Q2 24 | $3.7B | $2.4B |
| Q1 26 | — | $281.0M | ||
| Q4 25 | $-22.0M | $245.0M | ||
| Q3 25 | $18.0M | $245.0M | ||
| Q2 25 | $36.0M | $282.0M | ||
| Q1 25 | $-335.0M | $220.0M | ||
| Q4 24 | $0 | $222.0M | ||
| Q3 24 | $79.0M | $226.0M | ||
| Q2 24 | $-11.0M | $229.0M |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 32.4% | ||
| Q3 25 | 6.7% | 33.7% | ||
| Q2 25 | 6.3% | 34.2% | ||
| Q1 25 | 7.2% | 32.5% | ||
| Q4 24 | 6.2% | 32.7% | ||
| Q3 24 | 6.9% | 32.6% | ||
| Q2 24 | 5.6% | 33.5% |
| Q1 26 | — | 15.4% | ||
| Q4 25 | 1.1% | 13.8% | ||
| Q3 25 | 1.7% | 13.7% | ||
| Q2 25 | 1.8% | 15.9% | ||
| Q1 25 | -7.3% | 13.0% | ||
| Q4 24 | 1.3% | 13.8% | ||
| Q3 24 | 1.8% | 13.3% | ||
| Q2 24 | 1.2% | 14.8% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | -0.6% | 8.7% | ||
| Q3 25 | 0.5% | 8.7% | ||
| Q2 25 | 1.0% | 10.2% | ||
| Q1 25 | -9.3% | 8.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | 2.2% | 9.1% | ||
| Q2 24 | -0.3% | 9.6% |
| Q1 26 | — | $2.24 | ||
| Q4 25 | $-0.28 | $2.18 | ||
| Q3 25 | $0.17 | $2.16 | ||
| Q2 25 | $0.43 | $2.47 | ||
| Q1 25 | $-3.99 | $1.94 | ||
| Q4 24 | $0.00 | $1.95 | ||
| Q3 24 | $0.88 | $1.99 | ||
| Q2 24 | $-0.12 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $393.0M |
| Total DebtLower is stronger | $2.4B | $5.7B |
| Stockholders' EquityBook value | $1.7B | $7.7B |
| Total Assets | $8.8B | $16.7B |
| Debt / EquityLower = less leverage | 1.37× | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $393.0M | ||
| Q4 25 | — | $420.0M | ||
| Q3 25 | — | $432.0M | ||
| Q2 25 | — | $319.0M | ||
| Q1 25 | — | $188.0M | ||
| Q4 24 | — | $549.0M | ||
| Q3 24 | — | $764.0M | ||
| Q2 24 | — | $271.0M |
| Q1 26 | — | $5.7B | ||
| Q4 25 | $2.4B | $5.2B | ||
| Q3 25 | $2.4B | $5.2B | ||
| Q2 25 | $2.4B | $5.2B | ||
| Q1 25 | $2.4B | $5.9B | ||
| Q4 24 | $2.4B | $5.6B | ||
| Q3 24 | $2.4B | $5.6B | ||
| Q2 24 | $2.4B | $3.8B |
| Q1 26 | — | $7.7B | ||
| Q4 25 | $1.7B | $7.2B | ||
| Q3 25 | $1.8B | $7.3B | ||
| Q2 25 | $1.8B | $7.2B | ||
| Q1 25 | $1.7B | $6.9B | ||
| Q4 24 | $1.9B | $6.8B | ||
| Q3 24 | $2.1B | $6.8B | ||
| Q2 24 | $1.9B | $6.6B |
| Q1 26 | — | $16.7B | ||
| Q4 25 | $8.8B | $16.2B | ||
| Q3 25 | $9.0B | $16.2B | ||
| Q2 25 | $8.8B | $16.0B | ||
| Q1 25 | $8.6B | $15.8B | ||
| Q4 24 | $8.5B | $16.2B | ||
| Q3 24 | $9.4B | $16.1B | ||
| Q2 24 | $9.1B | $13.9B |
| Q1 26 | — | 0.74× | ||
| Q4 25 | 1.37× | 0.72× | ||
| Q3 25 | 1.35× | 0.71× | ||
| Q2 25 | 1.34× | 0.72× | ||
| Q1 25 | 1.44× | 0.85× | ||
| Q4 24 | 1.28× | 0.83× | ||
| Q3 24 | 1.12× | 0.83× | ||
| Q2 24 | 1.24× | 0.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $278.0M |
| Free Cash FlowOCF − Capex | $15.0M | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 1.8% | 3.9% |
| Cash ConversionOCF / Net Profit | — | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | $174.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $278.0M | ||
| Q4 25 | $80.0M | $465.0M | ||
| Q3 25 | $213.0M | $563.0M | ||
| Q2 25 | $172.0M | $544.0M | ||
| Q1 25 | $-45.0M | $314.0M | ||
| Q4 24 | $109.0M | $464.0M | ||
| Q3 24 | $263.0M | $356.0M | ||
| Q2 24 | $158.0M | $360.0M |
| Q1 26 | — | — | ||
| Q4 25 | $15.0M | $307.0M | ||
| Q3 25 | $134.0M | $419.0M | ||
| Q2 25 | $115.0M | $436.0M | ||
| Q1 25 | $-90.0M | $197.0M | ||
| Q4 24 | $45.0M | $341.0M | ||
| Q3 24 | $191.0M | $250.0M | ||
| Q2 24 | $88.0M | $268.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 10.9% | ||
| Q3 25 | 3.6% | 14.9% | ||
| Q2 25 | 3.1% | 15.8% | ||
| Q1 25 | -2.5% | 7.4% | ||
| Q4 24 | 1.3% | 13.0% | ||
| Q3 24 | 5.4% | 10.0% | ||
| Q2 24 | 2.4% | 11.2% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 1.8% | 5.6% | ||
| Q3 25 | 2.1% | 5.1% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 1.2% | 4.4% | ||
| Q4 24 | 1.8% | 4.7% | ||
| Q3 24 | 2.0% | 4.3% | ||
| Q2 24 | 1.9% | 3.8% |
| Q1 26 | — | 0.99× | ||
| Q4 25 | — | 1.90× | ||
| Q3 25 | 11.83× | 2.30× | ||
| Q2 25 | 4.78× | 1.93× | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | 2.09× | ||
| Q3 24 | 3.33× | 1.58× | ||
| Q2 24 | — | 1.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
